Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy - Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Pantelis Rousakis, Alexandra T. Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios C. Ziogas, Aristea-Maria Papanota, Marilyn Spyropoulou-Vlachou, Ioannis P. Trougakos - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Lippincott, Williams & Wilkins, HemaSphere, 6(3), p. e300, 2019

DOI: 10.1097/hs9.0000000000000300

Links

Tools

Export citation

Search in Google Scholar

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy

Journal article published in 2019 by Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Pantelis Rousakis, Alexandra T. Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Dimitrios C. Ziogas, Aristea-Maria Papanota, Marilyn Spyropoulou-Vlachou, Ioannis P. Trougakos and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO